tiprankstipranks
Trending News
More News >

Robinhood - New Portfolio

JOSE RAMIREZ

Robinhood
Individual Investor
Ranked #87,002 out of 820,151 TipRanks' Investors
Success Rate
57%
104 out of 181
profitable transactions
Average Return
49.41%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 4.41%
6-Month Return▲ 31.80%
12-Month Return▲ 43.76%
YTD Return▲ 26.41%
Total Return▼ 0.88%

Best Trade

Opened at
Closed at-
Gain▲ 2186.67%

Bio

Compound Dividends Portfolio

Performance

27.92%0-27.92%
▼ 12.86%
▼ 1.27%
▼ 5.52%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 3.90%
Mar 2025
▲ 1.84%
▼ 0.87%
▼ 1.67%
Apr 2025
▲ 12.20%
▲ 6.28%
▲ 6.44%
May 2025
▲ 6.24%
▲ 5.14%
▲ 18.98%
Jun 2025
▲ 27.92%
▲ 2.30%
▼ 1.35%
Jul 2025
▲ 4.87%
▲ 2.05%
▲ 3.58%
Aug 2025
▲ 5.67%
▲ 2.30%
▲ 4.86%
Sep 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 12.86%▼ 1.27%▼ 5.52%
▼ 1.80%▼ 5.57%▼ 3.90%
▲ 1.84%▼ 0.87%▼ 1.67%
▲ 12.20%▲ 6.28%▲ 6.44%
▲ 6.24%▲ 5.14%▲ 18.98%
▲ 27.92%▲ 2.30%▼ 1.35%
▲ 4.87%▲ 2.05%▲ 3.58%
▲ 5.67%▲ 2.30%▲ 4.86%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Meta Platforms
0%
▲ 0.23%
1
Open
Aug 20, 2025
Alphabet Class A
1.1%
▲ 27.35%
2
Buy
Aug 04, 2025
Amazon
0%
▼ 4.10%
1
Open
Jul 22, 2025
Viracta Therapeutics
▼ 98.00%
4
Close
Jul 16, 2025
Direxion Daily S&P 500 Bull 3x Shares
20.15%
▲ 90.74%
8
Buy
Mar 29, 2025
Walt Disney
6.07%
▲ 13.81%
8
Buy
Mar 29, 2025
Coca-Cola
7.39%
▲ 13.44%
10
Buy
Mar 29, 2025
Kraft Heinz
2.89%
▼ 20.97%
12
Buy
Mar 29, 2025
Energy Transfer
10.14%
▲ 67.70%
15
Buy
Mar 29, 2025
AT&T
6.46%
▲ 72.10%
13
Buy
Mar 29, 2025
Bank of America
3.02%
▲ 63.91%
8
Buy
Mar 29, 2025
Pfizer
0.85%
▼ 15.80%
3
Buy
Mar 29, 2025
aTyr Pharma
1.08%
▼ 55.81%
8
Buy
Mar 29, 2025
Nvidia
5.57%
▲ 42.73%
3
Buy
Mar 29, 2025
Tempest Therapeutics
0.64%
▼ 23.22%
3
Buy
Mar 29, 2025
PDS Biotechnology
0.05%
▼ 13.45%
1
Open
Mar 29, 2025
Stronghold Digital Mining
▼ 97.39%
3
Close
Mar 14, 2025
Bitfarms
0.04%
▲ 141.44%
1
Open
Mar 14, 2025
Carisma Therapeutics
0.01%
▼ 91.05%
5
Buy
Oct 29, 2024
Viking Therapeutics
0.11%
▲ 394.37%
8
Sell
Oct 29, 2024